Oliver Distler
Overview
Explore the profile of Oliver Distler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
555
Citations
17561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez Vertti Valdes M, Jungel A, Bitterli P, Devan J, Rehrauer H, Opitz L, et al.
Mol Med
. 2025 Mar;
31(1):94.
PMID: 40075262
Background: Patients with Complex Regional Pain Syndrome (CRPS) present prolonged, debilitating pain and functional impairment. Treatments are not disease-modifying due to the poorly understood underlying pathomechanisms. This study aimed to...
2.
White B, Furst D, Frech T, Kuwana M, Hummers L, Stevens W, et al.
ACR Open Rheumatol
. 2025 Mar;
7(3):e70004.
PMID: 40065521
Objectives: The RESOLVE-1 trial of lenabasum in diffuse cutaneous systemic sclerosis (dcSSc) allowed background immunosuppressive therapy (IST) at the discretion of individual investigators, and no significant differences were observed between...
3.
Steimer A, Gotschi A, Witte T, Scherer A, Brandli J, Nissen M, et al.
Clin Rheumatol
. 2025 Mar;
PMID: 40063233
Objectives: Anti-CD74 antibodies (Abs) have been proposed as a diagnostic biomarker in axial spondyloarthritis (axSpA). The aims of this study were to evaluate the association of these Abs with disease...
4.
Tschaler L, Jordan S, Aalokken T, Becker M, Brunborg C, Bruni C, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 40021203
Background: While the presence of distinct imaging abnormalities by high-resolution CT (HRCT) defines interstitial lung disease (ILD), there is a relative lack of validated methods to quantify these abnormalities in...
5.
Gyorfi A, Filla T, Polzin A, Tascilar K, Buch M, Trobs M, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e036730.
PMID: 40008525
Background: Systemic sclerosis (SSc) primary heart involvement (SSc-pHI) is one of the leading causes of mortality in SSc. We aimed to evaluate risk factors for SSc-pHI and its progression and...
6.
Allanore Y, Vonk M, Distler O, Azuma A, Mayes M, James A, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 39988350
Objective: We assessed adverse events and changes in forced vital capacity (FVC) in patients treated with open-label nintedanib over 148 weeks of SENSCIS-ON, the extension of the SENSCIS trial. Methods:...
7.
Buerki K, Toitou M, de Wit M, Grealis S, Ludwig S, Britt C, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 39929597
Background: Patient research partners (PRPs) are people living with a relevant disease who actively contribute to research. Their contribution is beneficial for any research project. Although the inclusion of PRPs...
8.
Spierings J, Bandini G, Allanore Y, Papa N, Denton C, Distler O, et al.
Semin Arthritis Rheum
. 2025 Feb;
71:152638.
PMID: 39914262
Objective: Autologous stem cell transplantation (AHSCT) is an established treatment in diffuse cutaneous systemic sclerosis (dcSSc). Optimal management of disease progression after AHSCT in dcSSc has not been defined. The...
9.
Fretheim H, Barua I, Bakland G, Dhainaut A, Halse A, Carstens M, et al.
Lancet Rheumatol
. 2025 Feb;
PMID: 39900089
Background: Gastrointestinal tract involvement is highly prevalent in systemic sclerosis, with few treatment options. We assessed the efficacy and safety of faecal microbiota transplantation using standardised anaerobic cultivated human intestinal...
10.
Moser L, Klambauer K, Diaz Machicado M, Frey D, Mergen V, Eberhard M, et al.
Invest Radiol
. 2025 Feb;
PMID: 39899807
Purpose: The aim of this study was to determine in a prospective patient study the accuracy of areal bone mineral density (aBMD) measurements with spectral localizer radiographs obtained with a...